An international multi-centre, randomised, double-blind, placebo controlled trial to evaluate the efficacy and safety of 0.5% and 2% Pro 2000/5 gels for the prevention of vaginally acquired human immunodeficiency virus (HIV) infections

Category Primary study
Registry of TrialsISRCTN registry
Year 2005
Null Hypothesis: That there is no difference in aquisition of HIV and sexually transmitted infections (STIs) in women using Pro2000 and placebo gel.
Epistemonikos ID: 339b156b7ab05d9ddcd364d4671bcab84a0d254e
First added on: Mar 20, 2020